NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/02/2024
Back to search
Official data from USPTO
AGC BIOLOGICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
AGC BIOLOGICS
ST13
US500000097526680Class
40, 42
Filing
97526680
Registration
7434649
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
07/02/2024
Trademark type
Word
Nice classes
40, 42
Filing date
07/29/2022
Registration date
07/02/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/02/2024
Last transaction
07/02/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/31/2018
First use in commerce
01/31/2018
Drawing code
4
Owner type
03
Owner location
Tokyo, JP
Examiner
DUBIN, DAVID
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
AGC Inc.
Representatives
Jeffrey H. Kaufman MUNCY, GEISSLER, OLDS & LOWE, P.C.
Technical classification
Nice Classes
Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Antibody physicochemical fractionation of culture fluid or for cells purification for otherscustom manufacture of pharmaceuticals; Antibody physicochemical fractionation of culture fluid or for cells purification for others in the nature of biomanufacturing for othersmanufacturing of pharmaceuticals using biological organisms in the manufacturing process; custom manufacture of biopharmaceuticals by pharmaceutical compounders by contract manufacturing organization
Class 42
Biotechnology research; chemical research; research and development services in the field of antibodies being antibody technology
Publications
History of USPTO decisions and trademark events.
29 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/02/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/28/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/28/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/19/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/19/2024
IUAF
USE AMENDMENT FILED
02/27/2024
EISU
TEAS STATEMENT OF USE RECEIVED
02/27/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/29/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/04/2023
PUBO
PUBLISHED FOR OPPOSITION
07/04/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/14/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/26/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
05/26/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/26/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
05/26/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/26/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/25/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/24/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/24/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/16/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/16/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/16/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/24/2023
GNRT
NON-FINAL ACTION E-MAILED
02/24/2023
CNRT
NON-FINAL ACTION WRITTEN
02/24/2023
DOCK
ASSIGNED TO EXAMINER
02/02/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/20/2022
NWAP
NEW APPLICATION ENTERED
08/02/2022
Continuous trademark protection
Get notified about every new filing that threatens AGC BIOLOGICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.